Most Recent Articles by Jason Harris
Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.
Researchers attributed nearly 5 million cases of blindness or impaired vision to complications from diabetes.
Higher pericardial adipose volumes were associated with increases in calcified atherosclerotic plaque.
Lower blood pressure was associated with significantly lower risk for cardiovascular events.
Patients with type 1 diabetes assigned to a 3-drug combination — dapagliflozin, liraglutide, and insulin — had superior blood glucose control compared with patients assigned to dapagliflozin monotherapy.
More Articles by Jason Harris
Endocrinology Advisor Articles
- Imaging Studies in Hypothyroidism Evaluation Linked to Unnecessary Risks
- Transoral Endoscopic Thyroidectomy Vestibular Approach: Safety and Outcomes
- Once-Weekly Omarigliptin Improves Glycemic Control in Type 2 Diabetes
- Insulin Glargine Associated With Breast Cancer Risk in T2D
- High Grip Strength Associated With Lower Risk for Diabetes-Related AEs
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- Bariatric Surgery: An Effective Treatment for Type 2 Diabetes
- Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- Increased Risk of Diabetes, Post-Diabetes Pneumonia for Patients With COPD
- Pancreatic Exocrine Dysfunction Occurs After Islet Autoimmunity in T1D
- T2D in African American Women Ups ER-negative Breast Cancer Risk
- High-Sensitivity CRP and LDL-C Predictive of Subsequent MACE in T2D
- Risks Associated With Denosumab Discontinuation